Equities

Varex Imaging Corp

Varex Imaging Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)16.51
  • Today's Change1.09 / 7.07%
  • Shares traded26.00
  • 1 Year change-15.12%
  • Beta0.5830
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy2
Outperform2
Hold1
Sell0
Strong Sell0

Share price forecast in USD

The 5 analysts offering 12 month price targets for Varex Imaging Corp have a median target of 21.00, with a high estimate of 30.00 and a low estimate of 16.00. The median estimate represents a 27.20% increase from the last price of 16.51.
High81.7%30.00
Med27.2%21.00
Low-3.1%16.00

Earnings history & estimates in USD

On Nov 19, 2024, Varex Imaging Corp reported 4th quarter 2024 earnings of 0.19 per share. This result exceeded the 0.09 consensus of the 4 analysts covering the company and under-performed last year's 4th quarter results by 57.78%.
The next earnings announcement is expected on Feb 04, 2025.
Average growth rate+25.80%
Varex Imaging Corp reported annual 2024 earnings of 0.55 per share on Nov 19, 2024.
Average growth rate+369.69%
More ▼

Revenue history & estimates in USD

Varex Imaging Corporation had 4th quarter 2024 revenues of 205.70m. This bettered the 199.39m consensus of the 5 analysts covering the company. This was 0.05% above the prior year's 4th quarter results.
Average growth rate-2.04%
Varex Imaging Corporation had revenues for the full year 2024 of 811.00m. This was 9.22% below the prior year's results.
Average growth rate+2.65%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.